Serotonin Receptor Antagonist

active

URL

http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.604

Version

20210306

PublisherAmerican Society of Clinical Oncology StewardDate2021-03-06T01:00:18-05:00Purpose

(Clinical Focus: The purpose of this value set is to represent concepts of medication for Serotonin Receptor Antagonist.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication for Serotonin Receptor Antagonist: Ondansetron, Granisetron, Palonosetron, Dolasetron.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)

Expansion

Code	Display	System
240912		http://www.nlm.nih.gov/research/umls/rxnorm
1810484		http://www.nlm.nih.gov/research/umls/rxnorm
1734399		http://www.nlm.nih.gov/research/umls/rxnorm
543218		http://www.nlm.nih.gov/research/umls/rxnorm
825003		http://www.nlm.nih.gov/research/umls/rxnorm
310599		http://www.nlm.nih.gov/research/umls/rxnorm
283504		http://www.nlm.nih.gov/research/umls/rxnorm
1740467		http://www.nlm.nih.gov/research/umls/rxnorm
1314133		http://www.nlm.nih.gov/research/umls/rxnorm
312084		http://www.nlm.nih.gov/research/umls/rxnorm
104894		http://www.nlm.nih.gov/research/umls/rxnorm
198052		http://www.nlm.nih.gov/research/umls/rxnorm
312087		http://www.nlm.nih.gov/research/umls/rxnorm
312086		http://www.nlm.nih.gov/research/umls/rxnorm
312085		http://www.nlm.nih.gov/research/umls/rxnorm
692695		http://www.nlm.nih.gov/research/umls/rxnorm
998028		http://www.nlm.nih.gov/research/umls/rxnorm
998033		http://www.nlm.nih.gov/research/umls/rxnorm
805448		http://www.nlm.nih.gov/research/umls/rxnorm
1728050		http://www.nlm.nih.gov/research/umls/rxnorm

{
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.139" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.138" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.137" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.141" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.140" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.81" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.336" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.136" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.135" ]
    } ]
  },
  "date" : "2021-03-06T01:00:18-05:00",
  "meta" : {
    "versionId" : "11",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "American Society of Clinical Oncology Steward",
  "jurisdiction" : [ {
    "coding" : [ {
      "system" : "urn:iso:std:iso:3166",
      "code" : "US"
    } ]
  } ],
  "purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts of medication for Serotonin Receptor Antagonist.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication for Serotonin Receptor Antagonist: Ondansetron, Granisetron, Palonosetron, Dolasetron.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)",
  "name" : "SerotoninReceptorAntagonist",
  "experimental" : false,
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "104894",
      "display" : "ondansetron 4 MG Disintegrating Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1314133",
      "display" : "2 ML ondansetron 2 MG/ML Prefilled Syringe",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1728050",
      "display" : "1.5 ML palonosetron 0.05 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1728055",
      "display" : "5 ML palonosetron 0.05 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1734399",
      "display" : "1 ML granisetron 1 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1740467",
      "display" : "2 ML ondansetron 2 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1790812",
      "display" : "0.625 ML dolasetron mesylate 20 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1810484",
      "display" : "0.4 ML granisetron 25 MG/ML Prefilled Syringe",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1947301",
      "display" : "2 ML palonosetron 0.125 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "198052",
      "display" : "ondansetron 4 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "2056929",
      "display" : "5 ML palonosetron 0.05 MG/ML Prefilled Syringe",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "240912",
      "display" : "granisetron 1 MG/ML Injectable Solution",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "283504",
      "display" : "ondansetron 2 MG/ML Injectable Solution",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "310006",
      "display" : "dolasetron 100 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "310007",
      "display" : "dolasetron 50 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "310599",
      "display" : "granisetron 1 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "312084",
      "display" : "ondansetron 24 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "312085",
      "display" : "ondansetron 0.8 MG/ML Oral Solution",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "312086",
      "display" : "ondansetron 8 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "312087",
      "display" : "ondansetron 8 MG Disintegrating Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "543218",
      "display" : "1 ML granisetron 0.1 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "692695",
      "display" : "ondansetron 16 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "825003",
      "display" : "168 HR granisetron 0.129 MG/HR Transdermal System",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "998028",
      "display" : "ondansetron 8 MG Oral Film",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "998033",
      "display" : "ondansetron 4 MG Oral Film",
      "version" : "05062024"
    } ],
    "total" : 25,
    "identifier" : "urn:uuid:d84fd3c7-3022-4007-9a7f-6e8e8f22754a",
    "timestamp" : "2024-06-14T11:33:08-04:00"
  },
  "title" : "Serotonin Receptor Antagonist",
  "extension" : [ {
    "valueString" : "American Society of Clinical Oncology Author",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueDate" : "2023-04-13",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2021-03-06",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "active",
  "id" : "2.16.840.1.113762.1.4.1116.604",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.604",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113762.1.4.1116.604"
  } ],
  "version" : "20210306"
}